Approved Study Database

Ref. No. Scientific Title Principal investigator
2020.094 Treatment efficacy for huge hepatocellular carcinoma >10cm: a comparative study of chemoembolization, radioembolization, and transarterial ethanol ablation Prof. YU Simon Chun Ho
余俊豪
2020.563 TreatmENT of AnastomotiC LeakagE after colorectal resection Dr. HO Man Fung
2014.242 Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients Professor Szeto Cheuk Chun
2015.588 Treatment of Atopic Dermatitis Complicated with Staphylococcus aureus –Using Tea Bath: A Pilot Study Prof. HON Ellis Kam Lun
韓錦倫
2019.504 Treatment of DM/Pre-DM in obese patients and its effects on microbiome, colonic adenoma and NAFLD Prof. SUNG Joseph Jao Yiu
2002.376 Treatment of Early Immunoglobulin A Nephropathy by Angiotension Convering Enzyme Inhibitor - A R andomized Controlled Trial Prof. Szeto Cheuk Chun
2018.603 Treatment of generalized anxiety disorder: A randomized controlled trial of an internet self-help program with minimal non-therapist support Ms. NG Yik Ying
吳奕瑩
2011.061 Treatment of Giant Cell Tumor of Bone by the Combination of Nitrogen-Bisphosponates and Pheny1 Transferase Inhibitors: An in vivo study KUMTA Shekhar Madhukar
2008.328 Treatment of Nonalcoholic Fatty Liver Disease with Probiotics & Prebiotics Dr Wong Wai Sun
2004.243 Treatment of Nonalcoholic Steatohepatitis with Rosiglitazone Dr. Hui Yui
2016.001 Treatment of Recurrent and Advanced Metastatic Colorectal Cancer (TRACC) Prof. MA Brigette
2002.354 Treatment of Tennis Elbow with Botulinum Toxin Prof. Hui C.F. Andrew
2023.224 Treatment outcome of Caesarean scar pregnancy under the classification of a novel reporting system Dr. YUNG Kar Kei
2017.371 TREATMENT OUTCOME OF HEPATOBLASTOMA AND PAEDIATRIC HEPATOCELLULAR CARCINOMA IN HONG KONG Dr. CHENG Frankie Wai Tsoi
2011.420 Treatment Outcomes, Safety Profiles, and Subgroup Response Characteristics of TKIs Compared to Standard Chemotherapy in treating patients with chronic-phase chronic myelogenous leukaemia (CP-CML): A Retrospective Study in an HA-managed hopsital Mr. Lee Tsz Yat
2024.021 Treatment Patterns and Clinical Outcomes of Recombinant Human Growth Hormone Therapy in Paediatric and Adolescent Patients: A Hong Kong Study Dr Chan Ching Ching Kate
陳晶晶
2014.656 Treatment resistant following the first-episode schizophrenia-spectrum disorder: a retrospective case-control study Dr Chung Wai Sau Dicky
2006.257 Treatment Response in Patients with Symptoms due to Gastroesophageal Reflux Disease Either with or without Esophagitis Treated with Pantoprazole Sodium 40mg o.d. over 8 Weeks (BY1023/M3-341) Dr. Wu Che Yuen Justin
2004.111 Treatment Strategy of Sevelamer in Peritoneal Dialysis Patients Dr. Chow Ka Ming
2005.048 Treatment with Peginterferon Alfa-2a (40 KD) (PEGASYS_) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment Prof. Chan Lik Yuen Henry
2024.435 Treatment, Disabilities and Cost-effectiveness Analysis of von Hippel-Lindau Syndrome Patients – A Retrospective Cohort Study Dr. LEUNG Ka Wai
2023.036 Tree nut oral immunotherapy in food-allergic children: an exploratory study Dr. LEUNG Agnes Sze Yin
梁詩彥
2016.694 Trends and Changes in incidence of retinopathy of prematurity over 10 years in a tertiary hospital in Hong Kong Dr. CHOW Po Chee
周寶姿
2023.493 Trends in hospitalisation for cancer and major modifiable risk factors for cancer in people with type 2 diabetes in Hong Kong between 2002 and 2019 Dr. WU Hongjiang
2021.300 Trends in incidence, length of hospitalization stay and readmission over 10 years by age and stroke subtype and differences on associated admission characteristics between young and elderly stroke patients: a population-level retrospective study Prof. YIP Benjamin Hon Kei
葉漢基
2012.256 Trends in preterm birth and perinatal mortality rates in Hong Kong, 1995 through 2011 Dr Hui Shuk Yi Annie
2023.080 Trends in the Incidence and Prevalence of Complications of Myopia among Hong Kong Chinese and Minority Ethnic Groups in Hong Kong Dr. ZHANG Xiujuan
2006.282 TRENDY - Experience with A Lipid Triad Modifying Drug Niaspan (Prolonged Release Micotinic Acid) in Hong Kong Patients with Dyslipidemia - A Hong Kong Post-Marketing Survelliance Study on Prolonged Release Nicotinic Acid (Niaspan) In Patients with High Ca TOMLINSON Brian
2011.393 Triage nurse perception versus patient's self reported pain intensity in the Emergency Department Miss Ho Man Ting
2006.370 Triage of Heart Failure Patients for Out-Patient Management at Emergency Department Using NT-proBNP CHAN Ho Ming Michael
2007.148 Trial of Medicines versus Surgery in the Management of Open-Angle Glaucoma in Chinese Eyes Prof. Nathan Greenleaf Congdon
2022.450 TriClip™Greater China Post Market Study Prof. LEE Alex Pui Wai
李沛威
2018.371 Tricuspid regurgitation after cardiac implantable electronic device implantation Dr. TAM Mark Tsz Kin
2024.520 Trimethylamine N-oxide-related metabolites as novel biomarkers for predicting the efficiency of aspirin treatment for preeclampsia prevention in high-risk pregnant women Prof. WANG Yao
Yao Wang
2023.057 Trimodal mapping technique of internal carotid artery with neuronavigation, indocyanine green fluorescence and Doppler ultrasonography during endoscopic transsphenoidal surgery Dr. YEUNG Leo Kam Tong
楊錦堂
2025.044 TRIP6 facilitates immune evasion to promote colorectal tumorigenesis by increasing cancer stemness: molecular mechanism and potential clinical application Prof. GOU Hongyan
2016.697 Triplet pregnancy with fetal reduction: experience in Hong Kong Dr. TSE Wing Ting
謝穎婷
2010.164 TRK-100STP Phase Iib/III Clinical Study Protocol Prof. SZETO Cheuk Chun
2010.346 TRK-100STP Phase IIb/III Clinical Study Protocol – Chronic Renal Failure (Primary Glomerular Disease / Nephrosclerosis) Dr. CHENG Yuk Lun
2022.120 Tropism and pathogenesis of influenza virus and coronavirus in human brain explant culture Dr. KO Ho
高浩
2020.220 Tropism and pathogenesis of SARS-CoV-2 in human macrophages Prof. HUI David Shu Cheong
許樹昌
2010.445 TRP channels in vascular system: vascular tone control and atherosclerotic development including studying mechanism of vasodilation control and neointima growth using discarded human internal mammary artery (LIMA) and saphenous vein samples at the time of Prof Yao Xiaoqiang
2023.461 TruBlue laser application to reduce the recurrence of cholesteatoma -- a prospective randomised control trial Dr. CHANG Wai Tsz
張慧子
2022.419 TruBlue LASER application versus Endoscopic excision and repair for chronic myringitis -- a prospective randomised control trial Prof. CHANG Wai Tsz
張慧⼦
2021.023 Tuberculosis in non-anti-TNF biologic and targeted therapy users for rheumatic diseases in Hong Kong: a population‐Based cohort study Dr. SO Ho
2019.445 Tumor immune microenvironment (TIME) to predict treatment response in breast cancer Dr. NI Yunbi
倪韵碧
2009.064 Tumor Suppressor Function of NOTCH-Regulator NUMB in EBV-Positive Nasopharyngeal Carcinoma Dr LO KWOK WAI
2021.540 TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL Dr. LOONG Herbert Ho Fung
龍浩鋒
2010.471 Turning point: a qualitative study of motivation of change in Chronic Pain patients Dr. Lam Chi Shan
2015.144 Twelve-month trajectory of acute insomnia in community-based adult population Dr. ZHANG Jihui
張繼輝

Page 254 of 265.